Johnson & Johnson vs. SELLAS Life Sciences Group, Inc. Common Stock
JNJ
Johnson & Johnson
$270.24 +1.07%
VS SLSSELLAS Life Sciences Group, Inc. Common Stock
$15.46 +15.37%
SELLAS Life Sciences Group, Inc. Common Stock (SLS) comes out ahead, leading on 2 of 3 compared factors.
Size & Scale
| JNJ | SLS | |
|---|---|---|
| Market Cap | $651.25 billion | $3.12 billion |
| Revenue (TTM) | $97.93 billion | — |
| Net Income (TTM) | $21.04 billion | — |
JNJ leads on 1 of 1 size & scale factors.
Valuation
| JNJ | SLS | |
|---|---|---|
| P/E Ratio | 31.35 | — |
| Price / Book | 7.66 | — |
| Price / Sales | 6.65 | — |
JNJ and SLS split the valuation factors evenly.
Profitability
| JNJ | SLS | |
|---|---|---|
| Net Margin | 21.48% | — |
| Return on Equity | 24.76% | — |
JNJ and SLS split the profitability factors evenly.
Dividend
| JNJ | SLS | |
|---|---|---|
| Dividend Yield | 1.98% | 6.22% |
| Payout Ratio | 62.18 | — |
SLS leads on 1 of 1 dividend factors.
Risk & Sentiment
| JNJ | SLS | |
|---|---|---|
| Short Interest | 0.67% | 0.06% |
SLS leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, SLS overview, SLS financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.